Pre-Match Physical of Participant and Referee

 

DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION

State Boxing Commission

RULE NO.:RULE TITLE:

61K1-3.016Pre-Match Physical of Participant and Referee

NOTICE OF CHANGE

Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 40 No. 94, May 14, 2014 issue of the Florida Administrative Register.

The corrections are in response to concerns stated by the Joint Administrative Procedures Committee in letters dated May 29, 2014 and March 31, 2015 and to concerns stated by the Commission at its meeting on March 6, 2015. The changes are as follows:

 

61K1-3.016(4)(i): Any indication that the participant is using or is under the influence of a prohibited substance contained within Rule 61K1-3.017, F.A.C. narcotics, drugs, stimulants, depressants, alcohol, local anesthetics or analgesics as to render the participant unable to recognize if the participant is seriously injured. If the physician finds any indication or evidence that the participant is using, is under the influence of unauthorized drugs or foreign substances such that the physician cannot make a definitive determination and therefore allows the match to proceed, the physician shall immediately advise the commission representative who shall ensure that a urine sample is taken and processed in accordance with Rule 61K1-3.017, F.A.C

 

61K1-3.016(4)(k)3.: Blindness defined as central visual acuity of 20/200 or less in the better worst eye with 20/40 or worse in the better eye with the best possible correction, possible in both eyes and/or a the widest diameter of the visual field of subtends an angular distance of no greater than 20 degrees or less in the better

 

61K1-3.016(8): Form BPR-0009-455, page 4, “Male Genitalia” and “Female Genitalia” have been deleted. Both sections are combined under the new section “Genitalia.”

 

61K1-3.016(9)(a): (a) Any participant who is suspended and issued Form BPR-0009-478, “Order of Automatic Suspension”, effective October 2012, as adopted in Rule 61K1-3.016, F.A.C., by the executive director, or any similar suspension issued by any other jurisdiction shall not participate until cleared by a physician licensed as an M.D. or D.O.  A physician may extend a medical suspension any time he or she believes it to be in the best interest for the safety of a participant. In all cases, the decision by the physician at the pre-match physical to issue or extend a medical suspension is final and not reviewable;

 

61K1-3.016(10)(b)2.c.: (10) Transgender Participants

(b) Transsexuals: Female to Male.

2. An individual Individuals undergoing sex reassignments from female to male after puberty may be eligible for participation in male matches under the following conditions:

c. Form DBPR FSBC 21, “Therapeutic Use Exemption and Medical Condition Explanation Form,”  March 2014, as adopted and incorporated in Rule 61K1-3.007, F.A.C. and a letter from the board certified physician responsible for the care of the participant will need to be submitted to the commission, and shall include the following:

i. Initial date of hormone therapy for the assigned sex (male);

ii. Date, location, surgeon, and surgical report of any surgery including breast reduction, gonadectomy, hysterectomy, or any other surgery involving genitalia;

iii. Hormone name/type, dose, and interval of administration over the past two years;

v. Lab reports of estradiol and testosterone levels within the past two years with a goal of serum estradiol levels within the normal range for a healthy man and testosterone levels within the range for healthy men, as determined under lab specific ranges as set forth below;

vi. Name, dose, and duration of any anti-estrogen treatment used over the past two years;

vii. Name, dose, and duration of any other medication used as part of the management of the transgender state.

c.d. No change.

i. through iii. No change.

(I) No change.

(II) No change.

(III) No change.

 

61K1-3.016(10)(c)1.: Participants should submit laboratory data required above which has been drawn from the participant no more than 1 year 6 months prior to the match date, including one value within one month of the match.  Participants shall not be permitted to participate if their estradiol or total testosterone levels are outside of the normal range.  If a value is found to be out of the normal range, the participant shall take action to correct the level by repeating the laboratory test and/or adjusting medication appropriately, which must be documented in an additional Form DBPR FSBC 20, “Pre Licensure Physical Sheet” revised September, 2015 effective 2014, adopted and incorporated by reference in the rule 61K1-3.007 herein.

 

61K1-3.016(11): All medical information provided to the commission directly shall not be released to any individual or entity without prior disclosure to the participants and only for the express purpose of determining the ability to participate in a match. Such medical information may be released to ringside physicians or representatives of the commission or the commission office.  Participants shall sign Form DBPR FSBC 20, “Pre-Licensure Physical Sheet”, as a release to permit the commission to release the medical information to the necessary individuals prior to the match for the express purpose of determining fitness to participate in a match.

 

61K1-3.016(14): The executive director or his or her designee shall, on medical advice whenever necessary, require that a referee undergo a physical examination prior to acting as a referee in any match.

 

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Paul Waters, Executive Director, Florida State Boxing Commission, 1940 North Monroe Street, Tallahassee, Florida 32399-2202.